...
首页> 外文期刊>Expert review of anti-infective therapy >Minor extended-spectrum beta-lactamases.
【24h】

Minor extended-spectrum beta-lactamases.

机译:次要广谱β-内酰胺酶。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Over the last few decades, various extended-spectrum beta-lactamases (ESBLs), which are remotely related to the classical TEM and SHV families, have emerged. Among these, CTX-M, VEB and PER variants are of particular interest due to their widespread dissemination. This article will focus on these emerging ESBLs. CTX-M was first identified from an Escherichia coli strain in Germany and since then, a rapidly growing family of ESBLs has formed worldwide. There are now more than 90 CTX-M variants. VEB-1 ESBL is widespread in Southeast Asia. It was first identified in an E. coli strain isolated from a Vietnamese boy in 1996. After the initial discovery, it spread to other species. PER-1, now reported from various continents, was restricted to Turkish hospitals for years after the first identification in a strain of Pseudomonas aeruginosa in 1993. The worldwide dissemination of ESBLs is a healthcare crisis that deserves special attention.
机译:在过去的几十年中,出现了与经典TEM和SHV家族遥相关的各种广谱β-内酰胺酶(ESBL)。其中,由于CTX-M,VEB和PER变体的广泛传播,它们特别受关注。本文将重点介绍这些新兴的ESBL。 CTX-M最早是从德国的大肠杆菌菌株中鉴定出来的,此后,在世界范围内形成了快速增长的ESBLs家族。现在有90多种CTX-M变体。 VEB-1 ESBL在东南亚很普遍。它是在1996年从越南男孩身上分离出的大肠杆菌中首次发现的。最初发现后,它传播到其他物种。自从1993年首次在铜绿假单胞菌中鉴定出PER-1之后,现在已经报道了来自各大洲的PER-1医院。多年来,ESBLs在世界范围内的传播是医疗危机,值得特别注意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号